4 Drug Cos. Strike $1.5M Deal In Namenda Pay-For-Delay Suit
Four generic-drug makers have agreed to pay a combined $1.54 million to settle allegations that they struck anticompetitive deals with an Actavis unit to keep a generic version of the Alzheimer's...To view the full article, register now.
Already a subscriber? Click here to view full article